메뉴 건너뛰기




Volumn 103, Issue 11, 2009, Pages 1500-1505

Comparison of the Effects of Ramipril Versus Telmisartan on High-Sensitivity C-Reactive Protein and Endothelial Progenitor Cells After Acute Coronary Syndrome

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; RAMIPRIL; TELMISARTAN; VASCULOTROPIN RECEPTOR 2;

EID: 65649117679     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.01.370     Document Type: Article
Times cited : (22)

References (21)
  • 2
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
    • Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145-153
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3    Bosch, J.4    Davies, R.5    Dagenais, G.6
  • 3
    • 12344329188 scopus 로고    scopus 로고
    • Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome
    • Jahn J., Hellmann I., Maass M., Giannitsis E., Dalhoff K., and Katus H.A. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome. Herz 29 (2004) 795-801
    • (2004) Herz , vol.29 , pp. 795-801
    • Jahn, J.1    Hellmann, I.2    Maass, M.3    Giannitsis, E.4    Dalhoff, K.5    Katus, H.A.6
  • 4
    • 15744392514 scopus 로고    scopus 로고
    • Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists
    • Bahlmann F.H., de Groot K., Mueller O., Hertel B., Haller H., and Fliser D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 45 (2005) 526-529
    • (2005) Hypertension , vol.45 , pp. 526-529
    • Bahlmann, F.H.1    de Groot, K.2    Mueller, O.3    Hertel, B.4    Haller, H.5    Fliser, D.6
  • 6
    • 0035906308 scopus 로고    scopus 로고
    • The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials
    • Moher D., Schulz K.F., and Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 (2001) 1987-1991
    • (2001) JAMA , vol.285 , pp. 1987-1991
    • Moher, D.1    Schulz, K.F.2    Altman, D.3
  • 8
    • 40949152378 scopus 로고    scopus 로고
    • Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau
    • Fadini G.P., Baesso I., Albiero M., Sartore S., Agostini C., and Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 197 (2008) 496-503
    • (2008) Atherosclerosis , vol.197 , pp. 496-503
    • Fadini, G.P.1    Baesso, I.2    Albiero, M.3    Sartore, S.4    Agostini, C.5    Avogaro, A.6
  • 9
    • 0037198998 scopus 로고    scopus 로고
    • Sample size and power determination for clustered repeated measurements
    • Liu A., Shih W.J., and Gehan E. Sample size and power determination for clustered repeated measurements. Stat Med 21 (2002) 1787-1801
    • (2002) Stat Med , vol.21 , pp. 1787-1801
    • Liu, A.1    Shih, W.J.2    Gehan, E.3
  • 10
    • 18844445944 scopus 로고    scopus 로고
    • Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis
    • Mitrovic V., Klein H.H., Krekel N., Kreuzer J., Fichtlscherer S., Schirmer A., Paar W.D., and Hamm C.W. Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis. Zeitschrift Kardiol 94 (2005) 336-342
    • (2005) Zeitschrift Kardiol , vol.94 , pp. 336-342
    • Mitrovic, V.1    Klein, H.H.2    Krekel, N.3    Kreuzer, J.4    Fichtlscherer, S.5    Schirmer, A.6    Paar, W.D.7    Hamm, C.W.8
  • 11
    • 17644391433 scopus 로고    scopus 로고
    • Irbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina
    • Biasucci L.M., Lombardi M., Piro M., Di Giannuario G., Liuzzo G., and Crea F. Irbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina. Heart 91 (2005) 670-671
    • (2005) Heart , vol.91 , pp. 670-671
    • Biasucci, L.M.1    Lombardi, M.2    Piro, M.3    Di Giannuario, G.4    Liuzzo, G.5    Crea, F.6
  • 12
    • 34547843478 scopus 로고    scopus 로고
    • Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders
    • Yamagishi S., Nakamura K., and Matsui T. Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders. Curr Mol Med 7 (2007) 463-469
    • (2007) Curr Mol Med , vol.7 , pp. 463-469
    • Yamagishi, S.1    Nakamura, K.2    Matsui, T.3
  • 13
    • 33846856622 scopus 로고    scopus 로고
    • C-reactive protein (CRP)-lowering agents
    • Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 24 (2006) 33-50
    • (2006) Cardiovasc Drug Rev , vol.24 , pp. 33-50
    • Prasad, K.1
  • 16
    • 37849053338 scopus 로고    scopus 로고
    • Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment
    • Uemura H., Ishiguro H., and Kubota Y. Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment. Int J Urol 15 (2008) 19-26
    • (2008) Int J Urol , vol.15 , pp. 19-26
    • Uemura, H.1    Ishiguro, H.2    Kubota, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.